[Dual antiplatelet treatment].
Atherothrombosis is the most frequent cause ofcerebrovascular and cardiovascular incidents. In spite of indisputable progress in treatment the residual risk remains high. Further means are needed to improve the prognosis for patients. Just as in the treatment of hypertension or dyslipidemia we are presently going down the route of combined medication, which affects the thrombosis process at different stages and thus increases the final effect. The article summaries the current possibilities for dual antiplatelet treatment and its indications.
Krupicka
J
J
Kardiochirurgické oddelení Nemocnice na Homolce Praha. jiri.krupicka@homolka.cz
D050197:Atherosclerosis / Q000150:complications*; D004359:Drug Therapy, Combination; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D013927:Thrombosis / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control
D010975:Platelet Aggregation Inhibitors